These indicate that butyrate may decrease the progression of CRC by altering the expression of tumour miRNAs, which causes changes in a number of critical signalling pathways, including c-Myc (Yuan and Subramanian, 2019). This evidence concerns the gene MYC and colorectal carcinoma.